Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors is a research paper published in Journal of Clinical Oncology (2024). On theSindex it has a DataRank of 1.8. It has been cited 75 times, with 71 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.650
From this paper's citation signal
Citation Network Contribution
1.1
From 48 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 71 citers.
NCI NIH HHS
Grant: P30 CA125123
NICHD NIH HHS
Grant: R33 HD105593
NCI NIH HHS
Grant: K12 CA090433
NHLBI NIH HHS
Grant: T32 HL092332
National Institutes of Health
Grant: 3P30CA125123-09S3
Baylor College of Medicine Cancer Center
National Institutes of Health
Grant: 4K12CA090433-15
Pediatric Oncology Clinical Research Training Program
FWCI
13.69
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals